Lexicon INPEFA® (Sotagliflozin) Gets Preferred Formulary Status With Express Scripts For Medicare

 INPEFA recently approved by FDA for treatment of heart failure

Express Scripts has determined that it will list INPEFA as a preferred product on Medicare national formularies on November 1, 2023

https://www.globenewswire.com/news-release/2023/10/09/2757020/0/en/INPEFA-Sotagliflozin-Receives-Preferred-Formulary-Status-With-Express-Scripts-For-Medicare-Patients.html